Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Whittaker, Sean J.
51  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Scoping review of genetic databases for rare dermatologic d..:

Schreidah, Celine M ; Reynolds, George Bingham ; Fahmy, Lauren M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203757/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Primary cutaneous lymphoma: recommendations for clinical tr..:

Olsen, Elise A ; Whittaker, Sean ; Willemze, Rein...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353153/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Advances in the understanding and treatment of Cutaneous T-..:

Bakr, Farrah S ; Whittaker, Sean J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729763/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Response to brentuximab vedotin versus physician's choice b..:

Kim, Youn H ; Prince, H. Miles ; Whittaker, Sean...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347228/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Response to brentuximab vedotin versus physician's choice b..:

Kim, Youn H ; Prince, H Miles ; Whittaker, Sean...
qt5zg5n6x3.  , 2021
Link: https://escholarship.org..
 
?
6

Spectrum of mutational signatures in T-cell lymphoma reveal..:

Jones, Christine L ; Degasperi, Andrea ; Grandi, Vieri...
doi:10.17863/CAM.64918.  , 2021
Link: https://doi.org/10.17863..
 
?
7

Randomized phase 3 ALCANZA study of brentuximab vedotin vs ..:

Horwitz, Steven M ; Scarisbrick, Julia J ; Dummer, Reinhard...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153035/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Spectrum of mutational signatures in T-cell lymphoma reveal..:

Jones, Christine L ; Degasperi, Andrea ; Grandi, Vieri...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889847/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Patient-reported quality of life in patients with relapsed/..:

Dummer, Reinhard ; Prince, Henry M ; Whittaker, Sean...
Dummer , R , Prince , H M , Whittaker , S , Horwitz , S M , Kim , Y H , Scarisbrick , J , Quaglino , P , Zinzani , P L , Wolter , P , Eradat , H , Pinter-Brown , L , Sanches , J A , Ortiz-Romero , P L , Akilov , O E , Geskin , L , Huen , A , Walewski , J , Wang , Y , Lisano , J , Richhariya , A , Feliciano , J , Zhu , Y , Bunn , V , Little , M , Zagadailov , E , Dalal , M R & Duvic , M 2020 , ' Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma : Results from the randomised phase III ALCANZA study ' , European Journal of Cancer , vol. 133 , pp. 120-130 . https://doi.org/10.1016/j.ejca.2020.04.010.  , 2020
Link: https://kclpure.kcl.ac.u..
 
?
10

Patient-reported quality of life in patients with relapsed/..:

Dummer, Reinhard ; Prince, Henry M ; Whittaker, Sean...
Dummer , R , Prince , H M , Whittaker , S , Horwitz , S M , Kim , Y H , Scarisbrick , J , Quaglino , P , Zinzani , P L , Wolter , P , Eradat , H , Pinter-Brown , L , Sanches , J A , Ortiz-Romero , P L , Akilov , O E , Geskin , L , Huen , A , Walewski , J , Wang , Y , Lisano , J , Richhariya , A , Feliciano , J , Zhu , Y , Bunn , V , Little , M , Zagadailov , E , Dalal , M R & Duvic , M 2020 , ' Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma : Results from the randomised phase III ALCANZA study ' , European Journal of Cancer , vol. 133 , pp. 120-130 . https://doi.org/10.1016/j.ejca.2020.04.010.  , 2020
Link: https://kclpure.kcl.ac.u..
 
?
11

Contribution of STAT3 and RAD23B in Primary Sézary Cells to..:

Butler, Rosie M ; Mckenzie, Robert C ; Jones, Christine L...
Butler , R M , Mckenzie , R C , Jones , C L , Flanagan , C E , Woollard , W J , Demontis , M , Ferreira , S , Tosi , I , John , S , Whittaker , S J & Mitchell , T J 2019 , ' Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance ' , Journal of Investigative Dermatology , vol. 139 , no. 9 , pp. 1975-1984.e2 . https://doi.org/10.1016/j.jid.2019.03.1130.  , 2019
Link: https://kclpure.kcl.ac.u..
 
?
12

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody,..:

Bagot, Martine ; Porcu, Pierluigi ; Marie-Cardine, Anne...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(19)30320-1.  , 2019
Link: https://hal.archives-ouv..
 
?
13

Contribution of STAT3 and RAD23B in Primary Sézary Cells to..:

Butler, Rosie M ; Mckenzie, Robert C ; Jones, Christine L...
Butler , R M , Mckenzie , R C , Jones , C L , Flanagan , C E , Woollard , W J , Demontis , M , Ferreira , S , Tosi , I , John , S , Whittaker , S J & Mitchell , T J 2019 , ' Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance ' , Journal of Investigative Dermatology , vol. 139 , no. 9 , pp. 1975-1984.e2 . https://doi.org/10.1016/j.jid.2019.03.1130.  , 2019
Link: https://kclpure.kcl.ac.u..
 
?
14

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody,..:

Bagot, Martine ; Porcu, Pierluigi ; Marie-Cardine, Anne...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(19)30320-1.  , 2019
Link: https://hal.science/hal-..
 
?
15

Mogamulizumab versus vorinostat in previously treated cutan..:

Kim, Youn H ; Bagot, Martine ; Pinter-Brown, Lauren...
info:eu-repo/semantics/altIdentifier/pmid/30100375.  , 2018
Link: http://hdl.handle.net/23..
 
1-15